Status:
COMPLETED
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
Lead Sponsor:
Colorado Center for Reproductive Medicine
Conditions:
Endometriosis
Infertility
Eligibility:
FEMALE
21-42 years
Phase:
PHASE4
Brief Summary
This prospective randomized trial evaluates whether one can predict which infertile women with endometriosis who are candidates for in vitro fertilization will benefit from prolonged therapy with a Gn...
Detailed Description
See summary
Eligibility Criteria
Inclusion
- Infertility
- Surgical diagnosis of endometriosis
- Normal ovarian reserve testing
- Regular menses
Exclusion
- Irregular menses
- Undiagnosed abnormal uterine bleeding
- Pregnancy
- Prior adverse reaction to any GnRH agonist
- Ovarian cystic or solid mass \> 3cm in mean diameter at study entry
- Use of a depot preparation of a GnRh agonist or any hormonal therapy for endometriosis within 6 months of study entry
- Current hepatic, renal, hematologic or psychiatric disorder
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT00621179
Start Date
March 1 2003
End Date
January 1 2010
Last Update
August 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Colorado Center for Reproductive Medicine
Lone Tree, Colorado, United States, 80124